Trelegy is delivered via the innovative Ellipta inhaler that provides accurate dosing through its consistent dose delivery mechanism and is associated with less inhaler teaching time compared to other commonly used inhalers, the company said. Estimated COPD prevalence in India is over 100 million and accounts for over 9.5 per cent of the total deaths in India.
